Energy & environment · 20/02/2019Updated: 10/17/2026 · 1 min read
U.S. Nuclear Regulatory Commission to Consider SHINE Medical Isotope Production Facility License Transfer
Summary
The NRC is reviewing an application by SHINE Medical Technologies, Inc. to transfer the Construction Permit for the SHINE Medical Isotope Production Facility to a holding company, Illuminated Holdings, Inc., and to amend the permit for administrative purposes.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →